The Foundation is pleased to welcome Claude Wasserstein to its Council, a dedicated group of goodwill ambassadors who work closely with the Board of Directors and staff to provide advice and assist with raising funds and building awareness.
Claude Wasserstein is the founder and CEO of Fine Day Ventures, an early-stage venture capital firm investing in innovative and impactful technology, specifically fintech, medtech, aerospace, cybersecurity, AI, and energy.
“Claude’s extensive knowledge, global relationships, and experience in investing in new technologies will have a major impact in helping the Foundation achieve its vision for focused ultrasound - improving the lives of millions of people around the world with a variety of serious medical disorders,” said Foundation Chairman Neal F. Kassell, MD.
Born in France, Claude is a graduate of Sweet Briar College’s class of 1982 and attended graduate school at the Sorbonne and the Ecole du Louvre in Paris. She began her career as a journalist for Newsweek, working out of the publication's Paris bureau. Prior to her investment career, Claude was a producer for CBS News, where she worked in the network's Dubai, Belfast, London, and Paris bureaus. During her time at CBS News, she won an Emmy for an investigative series.
Claude is a trustee of the King Hussein Cancer Center Foundation and the American Hospital in Paris Foundation; a member of the Metropolitan Museum International Council and the Brookings Institution; and a life trustee at WNET Channel 13. She is a member of the Council of Foreign Relations and Harvard’s Global Advisory Council and was recently awarded France’s Chevalier of the Legion of Honor. Claude resides in New York City.
“It’s hard not to be convinced by Neal Kassell, who is an inspirational leader in this field, and I’m honored to be able to support him and the Foundation,” said Claude. “I’m excited to be involved in a cutting-edge technology that can transform and save so many lives. I am pleased to join this dynamic group of individuals who all bring their different areas of expertise together for the single goal of advancing the field of focused ultrasound.”